HEALTH● LOWSep 24 · Sep 24, 2026, 8:32 PM
Merck Welireg, Eisai Lenvima combo approved for kidney cancer
Seeking Alpha Tech · global
A combination therapy involving Merck's Welireg and Eisai's Lenvima has received approval for treating kidney cancer. This development offers a new treatment option for patients with this condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH50m ago161 confirmed measles cases, one death reported in KozhikodeThe HinduHEALTH2h agoLongevity-first healthcare takes spotlight at Abu Dhabi Future Health SummitSouth China Morning PostHEALTH3h agoKenya’s Ebola cases test preparedness beyond NairobiAl Jazeera [en]HEALTH4h agoEven after explosive diarrhea outbreak Trump’s FDA looks to ease food requirementsThe Independent World